|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Product revenue, net | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Other income | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Other expense, net | |||||
| Net loss | |||||
| Net loss per common share: | |||||
| Basic net loss per common share (in dollars per share) | |||||
| Diluted net loss per common share (in dollars per share) | |||||
| Basic weighted average number of common shares outstanding (in shares) | |||||
| Diluted weighted average number of common shares outstanding (in shares) | |||||
Loading...